Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.60    1.05 (16.03%)
Bid:
7.20
Ask:
8.00
Spread: 0.80 (11.111%)
Market Cap: £9.08m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half Yearly Report

15 Dec 2010 12:00

RNS Number : 0065Y
Marechale Capital PLC
15 December 2010
 



15 December 2010

 

 

Marechale Capital plc

("Marechale" or the "Company")

 

Interim Results

 

Marechale Capital plc today announces its unaudited interim results for the six months ended 30 September 2010.

 

Chairman's Statement

 

Marechale has had an encouraging start to the current year and I am pleased to report its return to profitability in the six months to September 2010.

 

Marechale operates as a corporate finance advisory and capital fund raising business focusing on fundraising for growth companies and funds in 3 key sectors: renewable energy, leisure and infrastructure. Marechale runs a low cost business model working with its associates on a profit share basis. Marechale has had a high success rate of executing and completing projects the Company takes on. This is due to Marechale's due diligence process prior to taking on a new client and its proprietary investor relationships.

 

In the six month period to 30 September 2010, Marechale has completed 9 transactions which have generated sufficient cash fees to achieve a small profit. Corporate finance projects include advising a major private equity house on the refinancing of a retail business and advising an international shipping business on a co-operation agreement with a Scandinavian investment group. In the leisure sector, Marechale has completed development capital projects ranging from a fundraising of £1.5m for a Southern based, managed pub business, Heartstone Inns 2 plc, from UK wealth managers and a fundraising of £5.9m for a private equity growth capital investment in an established restaurant group.

 

Marechale has also had success in the renewable energy sector forming 2 clean energy development companies which have benefitted from the UK's new Feed-in-Tariffs ("FIT"). Firstly, Marechale raised development capital for Future Biogas Ltd ("Future Biogas"), an anaerobic digestion biogas business. The development capital has funded Future Biogas's first site and the company is awaiting planning permission for future sites. Marechale has, secondly, formed and funded a new solar development company based in the South West of the UK, West Country Renewables Ltd.

 

The above projects resulted in Marechale generating commission and advisory fees, warrants and founder equity which strengthen Marechale's balance sheet and could result in significant future gains for shareholders.

 

Marechale has a healthy pipeline of engaged corporate finance projects for the second half of the year, including entering the intermediary market with the planned launch of a new renewable fund for consented FIT plants, a new Venture Capital Trust, as well as a further fund raising for Heartstone Inns 2 plc.

 

Whilst market conditions are still challenging, the growing pipeline of businesses seeking funding and an increasing appetite amongst our client base to invest in high quality investment opportunities provide us with confidence for trading next year.

 

The Board continues to consider a number of acquisitions and investments in potentially complementary fund management or financial services businesses.

 

We hope to give you further positive updates on Marechale after the March 2011 year end.

 

Shareholders can get up to date information on Marechale on the Company's website www.marechalecapital.com, and a new website will be launched shortly.

 

Mark Warde-Norbury

15 December 2010

 

 

For further information please contact:

 

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

 

Tel: +44 (0)20 7628 5582

Smith & Williamson Corporate Finance

Azhic Basirov / David Jones

 

Tel: +44 (0)20 7131 4000

 

 

Marechale Capital PLC

Income Statement (unaudited)

Six months ended 30th September 2010

30 Sept

30 Sept

2010

2009

Continuing operations

Revenue

299,658

-

Cost of sales

(25,343)

-

Gross profit

274,315

-

Administrative expenses

(264,935)

(315,160)

Operating profit/ (loss)

9,380

(315,160)

Investment revenues

646

1,748

Other gains and losses

-

(1,408)

Profit/ (loss) before tax

10,026

(314,820)

Corporation tax charge

-

-

Profit/ (loss) for the period on continuing operations

10,026

(314,820)

Loss for the period on discontinued operations*

 

Profit/ (Loss) for the period

 

 

 

 

Earnings per share

-

 

 

10,026

(58,353)

 

 

(373,173)

Basic and diluted

47,437,410 shares (2009:42,741,106)

0.02p

(0.87p)

* On 14th September 2009 the AIM Broking and PLUS Adviser businesses and associated assets were sold to Whim Gully Capital LLP for a consideration of £200,000.

Marechale Capital PLC

Balance Sheet (unaudited)

As at 30th September 2010

30 Sept

30 Sept

2010

2009

Non current assets

Property, plant and equipment

-

15,929

Current assets

Available for sale investments

67,707

110,614

Trading investments

-

6,089

Trade and other receivables

144,848

241,037

Cash and cash equivalents

294,156

541,153

506,711

898,893

Total assets

506,711

914,822

Current liabilities

Trade and other payables

(94,682)

(132,179)

Corporation tax

-

19,281

Total current liabilities

(94,682)

(112,898)

Net assets

412,029

801,923

Equity

Capital and reserves attributable to equity shareholders

Share capital

2,371,872

2,137,055

Share premium account

1,177,452

1,177,452

Revaluation reserves

28,324

36,773

Other reserves

(50,254)

683,591

Retained earnings

(3,115,365)

(3,232,948)

412,029

801,923

 

 

 

 

 

 

 

 

 

 

 

 

Cash Flow Statement (unaudited)

Six months ended 30th September 2010

30 Sept

30 Sept

2010

2009

Net cash from operating activities

Operating profit/ (loss) from continuing operations

9,380

(315,160)

Depreciation

-

21,000

Operating loss from discontinued operations

 -

 (58,353)

Share based payments re discontinued operations

-

 

80,000

Operating cash flows before movements in working capital

9,380

(272,513)

Movement in working capital

(Increase)/ decrease in receivables

(81,874)

91,960

(Decrease)/ increase in payables

(23,428)

(30,963)

(105,302)

60,998

Operating cash flow

(95,922)

(211,515)

Investment activities

Interest receivable

646

1,749

Proceeds on disposal of trading investments

-

(1)

Proceeds on disposal of available for sale investments

-

-

Expenditure on tangible fixed assets

-

-

Expenditure on trading investments

(10,000)

-

Cash flow from investing activities

(9,354)

1,748

Financing

Issue of share capital

-

-

Interest payable

-

-

Cash flow from financing activities

-

-

Net increase/(decrease) in cash and cash equivalents

(105,276)

(209,767)

Cash and cash equivalents at start of period

399,432

750,921

Cash and cash equivalents at end of period

294,156

541,153

Increase/(decrease) in cash and cash equivalents

(105,276)

(209,767)

 

This financial information has been in accordance with IFRS and International Financial Reporting

Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those

parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior periods

being reported on the same basis.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FELFFBLFFFBF
Date   Source Headline
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.